1-8 of 8
Joong-Won Park
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma

Subject Area:
Gastroenterology , Oncology
Lorenza Rimassa, Robin Kate Kelley, Tim Meyer, Baek-Yeol Ryoo, Philippe Merle, Joong-Won Park, Jean-Frederic Blanc, Ho Yeong Lim, Albert Tran, Yi-Wah Chan, Paul McAdam, Evelyn Wang, Ann-Lii Cheng, Anthony B. El-Khoueiry, Ghassan K. Abou-Alfa
Journal: Liver Cancer
Liver Cancer (2022) 11 (1): 38–47.
https://doi.org/10.1159/000519867
Published Online: 03 December 2021
View article titled, Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma
Open the PDF for Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma in another window
Journal Articles

Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma

Subject Area:
Gastroenterology , Oncology
Keun Soo Ahn, Daniel R. O’Brien, Yong Hoon Kim, Tae-Seok Kim, Hiroyuki Yamada, Joong-Won Park, Sang-Jae Park, Seoung Hoon Kim, Cheng Zhang, Hu Li, Koo Jeong Kang, Lewis R. Roberts
Journal: Liver Cancer
Liver Cancer (2021) 10 (6): 593–605.
https://doi.org/10.1159/000516957
Published Online: 22 September 2021
View article titled, Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma
Open the PDF for Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma in another window
Journal Articles

Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis

Subject Area:
Gastroenterology , Oncology
Dominik Bettinger, David J. Pinato, Michael Schultheiss, Rohini Sharma, Lorenza Rimassa, Tiziana Pressiani, Michela E. Burlone, Mario Pirisi, Masatoshi Kudo, Joong Won Park, Nico Buettner, Christoph Neumann-Haefelin, Tobias Boettler, Nasrin Abbasi-Senger, Horst Alheit, Wolfgang Baus, Oliver Blanck, Sabine Gerum, Mathias Guckenberger, Daniel Habermehl, Christian Ostheimer, Oliver Riesterer, Jörg Tamihardja, Anca-Ligia Grosu, Robert Thimme, Thomas Baptist Brunner, Eleni Gkika
Journal: Liver Cancer
Liver Cancer (2019) 8 (4): 281–294.
https://doi.org/10.1159/000490260
Published Online: 12 July 2018
View article titled, Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis
Open the PDF for Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis in another window
Journal Articles

Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study

Subject Area:
Gastroenterology , Oncology
Masatoshi Kudo, Yoon-Koo Kang, Joong-Won Park, Shukui Qin, Yoshitaka Inaba, Eric Assenat, Yoshiko Umeyama, Maria José Lechuga, Olga Valota, Yosuke Fujii, Jean-Francois Martini, J. Andrew Williams, Shuntaro Obi
Journal: Liver Cancer
Liver Cancer (2018) 7 (2): 148–164.
https://doi.org/10.1159/000484620
Published Online: 29 May 2018
View article titled, Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study
Open the PDF for Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study in another window
Journal Articles

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

Subject Area:
Gastroenterology , Oncology
Clarence Yen, Rohini Sharma, Lorenza Rimassa, Tadaaki Arizumi, Dominik Bettinger, Huay Yee Choo, Tiziana Pressiani, Michela E. Burlone, Mario Pirisi, Laura Giordano, Anisa Abdulrahman, Masatoshi Kudo, Robert Thimme, Joong Won Park, David James Pinato
Journal: Liver Cancer
Liver Cancer (2017) 6 (4): 313–324.
https://doi.org/10.1159/000480441
Published Online: 16 September 2017
View article titled, Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study
Open the PDF for Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study in another window
Journal Articles

Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area

Subject Area:
Gastroenterology , Oncology
Hee-Won Kwak, Joong-Won Park, Young Hwan Koh, Ju Hee Lee, Ami Yu, Byung-Ho Nam
Journal: Liver Cancer
Liver Cancer (2016) 5 (1): 21–36.
https://doi.org/10.1159/000367756
Published Online: 15 December 2015
View article titled, Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area
Open the PDF for Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area in another window
Journal Articles

Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma

Subject Area:
Gastroenterology , Oncology
Jean-Luc Raoul, Joong-Won Park, Yoon-Koo Kang, Richard S Finn, Jun Suk Kim, Winnie Yeo, Blasé N Polite, Yee Chao, Ian Walters, Christine Baudelet, Riccardo Lencioni
Journal: Liver Cancer
Liver Cancer (2014) 3 (3-4): 439–450.
https://doi.org/10.1159/000343872
Published Online: 15 August 2014
View article titled, Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma
Open the PDF for Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma in another window
Journal Articles

Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future

Subject Area:
Gastroenterology , Oncology
Hwi Young Kim, Joong-Won Park
Journal: Liver Cancer
Liver Cancer (2014) 3 (1): 9–17.
https://doi.org/10.1159/000343854
Published Online: 27 February 2014
View article titled, Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future
Open the PDF for Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future in another window